# Amycretin in type 2 diabetes: HbA1c drop at 36 weeks

Source: https://pepvault.app/research/amycretin-mora-2026-42532080

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Amycretin](https://pepvault.app/research#amycretin)

Randomized trial · people

# Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In adults with type 2 diabetes, every amycretin dose tested from 0.4 to 40 mg lowered HbA1c more than placebo over 36 weeks, and the side effects were mostly gut-related.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 262
- **Published:** 2026
- **Journal:** Lancet

## What they tested

The team tested how different weekly doses of amycretin (now called zenagamtide), injected under the skin, changed blood sugar control and safety compared with placebo in adults with type 2 diabetes.

## How the study was done

A randomized, double-blind, placebo-controlled phase 2 trial that enrolled 262 adults with type 2 diabetes at 83 sites in 11 countries; everyone was on a steady metformin dose, and some also used an SGLT2 inhibitor. For 36 weeks, each person got one of six weekly doses (0.4, 1.5, 5, 10, 20 or 40 mg) or placebo (a dummy shot), starting at 0.2 mg and stepping up every 4 weeks.

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Average HbA1c (a 3-month average of blood sugar) was 7.8% at the start. By week 36, it fell by 0.9% in the 0.4 mg arm, a difference of -0.77% versus placebo (95% CI -1.26 to -0.28), and by 1.7% in the 40 mg arm, a difference of -1.56% versus placebo (95% CI -2.05 to -1.07). Most side effects involved the gut and were mild to moderate. Serious adverse events occurred in 21 (8%) of 261 treated participants, 3 of them on placebo, and no one died.

## What it doesn’t show

This was a 36-week dose-finding trial with a small placebo group of 37 people, all of them adults with type 2 diabetes on background metformin. It was funded by Novo Nordisk.

## The paper

Mora et al. Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial. Lancet. 2026.

- [PubMed (PMID 42532080)](https://pubmed.ncbi.nlm.nih.gov/42532080/)
- [The paper (DOI 10.1016/S0140-6736(26)01248-1)](https://doi.org/10.1016/S0140-6736%2826%2901248-1)
- [ClinicalTrials.gov (NCT06542874)](https://clinicaltrials.gov/study/NCT06542874)

## The compound

- [Amycretin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

## More studies on Amycretin

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026) Randomized trial · people · 2026
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025) Randomized trial · people · 2025
- [Amycretin: side effects all mild or moderate in first human trial](https://pepvault.app/research/amycretin-gasiorek-2025) Randomized trial · people · 2025
- [Amycretin: similar drug exposure with kidney impairment in phase 1](https://pepvault.app/research/amycretin-oldenburg-2026) Clinical trial · people · 2026
- [Amycretin cut body weight by 18% in obese rats over 21 days](https://pepvault.app/research/amycretin-kuhre-2025) Animal study · mice and rats · 2025
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

## The library

- [Amycretin](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
